AU2005299341A1 - Method to promote wound healing - Google Patents

Method to promote wound healing Download PDF

Info

Publication number
AU2005299341A1
AU2005299341A1 AU2005299341A AU2005299341A AU2005299341A1 AU 2005299341 A1 AU2005299341 A1 AU 2005299341A1 AU 2005299341 A AU2005299341 A AU 2005299341A AU 2005299341 A AU2005299341 A AU 2005299341A AU 2005299341 A1 AU2005299341 A1 AU 2005299341A1
Authority
AU
Australia
Prior art keywords
substance
wound
mammal
administered
met
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005299341A
Other languages
English (en)
Inventor
Mark L. Witten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuneregen Biosciences Inc
Original Assignee
Immuneregen Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuneregen Biosciences Inc filed Critical Immuneregen Biosciences Inc
Publication of AU2005299341A1 publication Critical patent/AU2005299341A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2005299341A 2004-10-27 2005-10-25 Method to promote wound healing Abandoned AU2005299341A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62201504P 2004-10-27 2004-10-27
US60/622,015 2004-10-27
PCT/US2005/038646 WO2006047625A2 (en) 2004-10-27 2005-10-25 Method to promote wound healing

Publications (1)

Publication Number Publication Date
AU2005299341A1 true AU2005299341A1 (en) 2006-05-04

Family

ID=36228442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005299341A Abandoned AU2005299341A1 (en) 2004-10-27 2005-10-25 Method to promote wound healing

Country Status (6)

Country Link
US (1) US20080318869A1 (cg-RX-API-DMAC7.html)
EP (1) EP1809313A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008518020A (cg-RX-API-DMAC7.html)
AU (1) AU2005299341A1 (cg-RX-API-DMAC7.html)
CA (1) CA2585265A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047625A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101621149B1 (ko) 2014-07-09 2016-05-16 계명대학교 산학협력단 만성 창상용 동물 모델
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
KR101825041B1 (ko) * 2016-04-07 2018-02-02 주식회사 바이오솔루션 물질 p를 포함하는 상처치유용 약학 조성물
WO2018014016A1 (en) * 2016-07-15 2018-01-18 New Amsterdam Sciences Substance and method for treating radiation exposure
JP6901801B2 (ja) * 2017-06-14 2021-07-14 バイオソリューション カンパニー・リミテッドBio Solution Co Ltd 物質pを含むしわの改善または抗炎症化粧料組成物
KR102158969B1 (ko) * 2018-10-19 2020-09-23 주식회사 바이오솔루션 물질 p를 포함하는 난치성 궤양 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616562A (en) * 1990-04-27 1997-04-01 Murphy; Christopher J. Methods and compositions using substance P to promote wound healing
US5945508A (en) * 1996-07-23 1999-08-31 Witten; Mark L. Substance P treatment for immunostimulation
JP4096115B2 (ja) * 2000-08-10 2008-06-04 輝夫 西田 皮膚創傷治癒促進剤
AU7776701A (en) * 2000-08-10 2002-02-25 Santen Pharmaceutical Co Ltd Skin wound healing promoters
US20060153789A1 (en) * 2002-12-18 2006-07-13 Witten Mark L Stimulation of hair regrowth
US20070154448A1 (en) * 2005-11-22 2007-07-05 Ted Reid Methods and compositions using Substance P to promote wound healing

Also Published As

Publication number Publication date
EP1809313A4 (en) 2008-01-23
WO2006047625A2 (en) 2006-05-04
WO2006047625A3 (en) 2006-07-27
EP1809313A2 (en) 2007-07-25
CA2585265A1 (en) 2006-05-04
US20080318869A1 (en) 2008-12-25
JP2008518020A (ja) 2008-05-29

Similar Documents

Publication Publication Date Title
RU2255737C2 (ru) Анальгезирующие композиции, содержащие бупренорфин
Straube et al. Studies with cysteinamine and cysteine in x-irradiated animals
US20080318869A1 (en) Method to Promote Wound Healing
JP5823486B2 (ja) 放射線および熱の複合損傷の治療方法
Reyes-Vazquez et al. Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus
Hope et al. Release of immunoreactive galanin in the spinal cord of rats with ankle inflammation: studies with antibody microprobes
JP6150374B2 (ja) 放射線被ばく治療剤及び放射線被ばく治療方法
US20230270739A1 (en) Methods and Compositions for Treating Pain While Minimizing the Risk of Opioid Addiction
Mazarati et al. Felbamate in experimental model of status epilepticus
JPH07165582A (ja) 免疫抗癌剤の抗癌効果増強剤
Renecker et al. Antagonism of xylazine hydrochloride with yohimbine hydrochloride and 4-aminopyridine in captive wapiti
AU2445900A (en) Regulation of anaesthesia
RU2232501C2 (ru) Способ повышения естественной резистентности животных
JP2008518020A5 (cg-RX-API-DMAC7.html)
KR20050086819A (ko) 알파 티모신을 사용한 방사능 손상에 대한 보호방법
EP4506012A1 (en) Use of extracts from rabbit skin inflamed by vaccinia virus in treatment of alzheimer's disease
US20240415937A1 (en) Theophylline-loaded collagen nanoparticles
Reuter et al. Current capture technique and drug dosage regime for the immobilization and tranquilization of free-ranging black rhinoceros (Diceros bicornis bicornis) in Namibia
CN121846176A (zh) 一种止痛穴位贴膏及其制备方法
JP2001057828A (ja) 癌性疼痛モデル動物及びそれを用いた癌性疼痛の強さの評価方法
Sloan et al. Diazepam-treated female rats: flumazenil-and PK 11195-induced withdrawal in the hippocampus CA1
RU2018310C1 (ru) Средство для лечения длительно незаживающих ран и трофических язв
RU2061492C1 (ru) Противовоспалительное средство для лечения ретикулоперитонитов крупного рогатого скота
WO2015195894A1 (en) Methods and compositions for the modulation of beta-endorphin levels
Khorunzhii et al. Temporal patterns of spontaneous activity of auditory cortex neurons in lightly anesthetized and awake mice

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted